PAREXEL International to Present at Credit Suisse 18th Annual Healthcare Conference

BOSTON, Nov. 10 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Credit Suisse 18th Annual Healthcare Conference in Phoenix, AZ. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a formal presentation on PAREXEL at 12:00 p.m. EST on Friday, November 13, 2009.

The presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at www.PAREXEL.com. After the conference, a PDF version of this presentation will be available under the "Webcasts and Presentations" section on our "Investors" homepage.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 70 locations throughout 52 countries around the world, and has over 9,130 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

    CONTACT:  Jill Baker, Vice President of Investor Relations
              +1-781-434-4118